LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. The company is headquartered in New York, New York. Show more
ONE PENNSYLVANIA PLAZA, NEW YORK, NY, UNITED STATES, 10119, New York, NY, 10119, USA
Market Cap
1.29B
52 Wk Range
$13.36 - $46.01
Previous Close
$42.84
Open
$42.99
Volume
563,748
Day Range
$42.56 - $46.00
Enterprise Value
787.2M
Cash
320.7M
Avg Qtr Burn
-23.29M
Insider Ownership
0.27%
Institutional Own.
-
Qtr Updated
03/31/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|